pCI-neo-sOVA Citations (10)
Originally described in: Kupfer-type immunological synapse characteristics do not predict anti-brain tumor cytolytic T-cell function in vivo.Yang J, Sanderson NS, Wawrowsky K, Puntel M, Castro MG, Lowenstein PR Proc Natl Acad Sci U S A. 2010 Mar 9. 107(10):4716-21. PubMed Journal
Articles Citing pCI-neo-sOVA
| Articles |
|---|
| Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responses. Xiao G, Li X, Kumar A, Cui Z. Eur J Pharm Biopharm. 2012 Sep;82(1):212-7. doi: 10.1016/j.ejpb.2012.06.012. Epub 2012 Jul 3. PubMed |
| pH-sensitive carbonate apatite nanoparticles as DNA vaccine carriers enhance humoral and cellular immunity. He P, Takeshima SN, Tada S, Akaike T, Ito Y, Aida Y. Vaccine. 2014 Oct 29;32(47):6199-205. doi: 10.1016/j.vaccine.2014.09.032. Epub 2014 Sep 26. PubMed |
| Artificial Loading of ASC Specks with Cytosolic Antigens. Sahillioglu AC, Ozoren N. PLoS One. 2015 Aug 10;10(8):e0134912. doi: 10.1371/journal.pone.0134912. eCollection 2015. PubMed |
| B lymphocytes as direct antigen-presenting cells for anti-tumor DNA vaccines. Colluru VT, McNeel DG. Oncotarget. 2016 Oct 18;7(42):67901-67918. doi: 10.18632/oncotarget.12178. PubMed |
| Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses. Kang S, Ahn S, Lee J, Kim JY, Choi M, Gujrati V, Kim H, Kim J, Shin EC, Jon S. J Control Release. 2017 Jun 28;256:56-67. doi: 10.1016/j.jconrel.2017.04.024. Epub 2017 Apr 18. PubMed |
| Designing immunostimulatory double stranded messenger RNA with maintained translational activity through hybridization with poly A sequences for effective vaccination. Uchida S, Yoshinaga N, Yanagihara K, Yuba E, Kataoka K, Itaka K. Biomaterials. 2018 Jan;150:162-170. doi: 10.1016/j.biomaterials.2017.09.033. Epub 2017 Sep 27. PubMed |
| Impaired antigen-specific lymphocyte priming in mice after Toll-like receptor 4 activation via induction of monocytic myeloid-derived suppressor cells. Tsukamoto H, Kozakai S, Kobayashi Y, Takanashi R, Aoyagi T, Numasaki M, Ohta S, Tomioka Y. Eur J Immunol. 2019 Apr;49(4):546-563. doi: 10.1002/eji.201847805. Epub 2019 Feb 1. PubMed |
In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.
Wang X, Tokheim C, Gu SS, Wang B, Tang Q, Li Y, Traugh N, Zeng Z, Zhang Y, Li Z, Zhang B, Fu J, Xiao T, Li W, Meyer CA, Chu J, Jiang P, Cejas P, Lim K, Long H, Brown M, Liu XS.
Cell. 2021 Oct 14;184(21):5357-5374.e22. doi: 10.1016/j.cell.2021.09.006. Epub 2021 Sep 27.
PubMed
Associated Plasmids |
| Circulating Tregs Accumulate in Omental Tumors and Acquire Adipose-Resident Features. Liu M, Starenki D, Scharer CD, Silva-Sanchez A, Molina PA, Pollock JS, Cooper SJ, Arend RC, Rosenberg AF, Randall TD, Meza-Perez S. Cancer Immunol Res. 2022 May 3;10(5):641-655. doi: 10.1158/2326-6066.CIR-21-0880. PubMed |
| B cells require licensing by dendritic cells to serve as primary antigen-presenting cells for plasmid DNA. Rastogi I, McNeel DG. Oncoimmunology. 2023 May 15;12(1):2212550. doi: 10.1080/2162402X.2023.2212550. eCollection 2023. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.